Tissue polypeptide antigen (TPA) is an unconjugated protein that is widely distributed in human epithelial tissues.' It was first isolated from the water insoluble residue of carcinomas in the search for a common antigen associated with tumour.2 Antibodies raised against the major subunit, TPA B 1, have been used in serological studies of patients with malignant tumours, and it has been suggested that increased serum concentration of TPA may indicate the presence of a malignant epithelial neoplasm.3 -Increased concentrations of circulating TPA have, however, been detected in blood in several benign conditions.6 7 Lundstrom etal7 showed that patients with acute hepatitis may have increased serum TPA concentrations but the tissue expression of this protein in liver disease has not been reported as far as we know.
The general tissue distribution of TPA suggests that it may be related to cytokeratins,2 the intermediate filament proteins of epithelial cells,' 8-10 but their precise biochemical relation is uncertain. The distribution of cytokeratins in human liver has been described in biochemical and immunohistochemical studies." -17 In normal liver hepatocytes differ from bile duct epithelium in their cytokeratin profile, and certain liver diseases may be associated with abnormalities in hepatocytic cytokeratin metabolism. This study therefore aimed to investigate the distribution of TPA in normal adult and fetal liver, and in various liver diseases, and to compare this with the distribution of low molecular weight and high molecular weight cytokeratins.
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LIVER BIOPSY SPECIMENS
Surgical wedge biopsy specimens and percutaneous needle biopsy specimens of liver were taken from the files of the University Department of Pathology, Western Infirmary, Glasgow. Tissue was available from patients with histologically normal liver taken at staging laparotomies (n = 8), congenital hepatic fibrosis (n = 3), fatty liver (n = 8), alcoholic hepatitis (n = 11), alcoholic cirrhosis (n = 15), extrahepatic biliary obstruction (n = 6), cholestasis induced by drugs (n = 4), autoimmune chronic active hepatitis (n = 7), primary biliary cirrhosis (n = 11), primary sclerosing cholangitis (n = 2), hepatocellular carcinoma (n = 4) and cholangiocarcinoma (n = 4). The peroxidase-antiperoxidase (PAP) technique was used on sections treated with anti-TPA and antikeratin,"9 and the avidin-biotin peroxidase method was used on sections treated with CAM 5.2.20 Peroxidase labelling in slides treated with PAP and with avidin-biotin was shown using the method of Graham and Karnovsky.2' Sections were subsequently counterstained with haematoxylin and read under a Leitz III microscope; Nomarski filters and phase contrast were used to accentuate contrast.
Results

DISTRIBUTION OF TPA AND CYTOKERATINS IN NORMAL ADULT AND FETAL LIVER
In normal adult liver staining with anti-TPA antibody was confined to bile duct epithelium, where it was seen throughout the cytoplasm ( fig 1) ; bile duct radicles of all calibres showed similar appearances. Staining with antikeratin was also limited to bile duct epi- Burt, Stewart, Aitchison, MacSween thelial cells, and the intracellular distribution was similar to that of TPA. Using the methods outlined above, staining was more intense with anti-TPA than with antikeratin. The intensity of staining with both antibodies was enhanced by adding trypsin; in some sections reactivity to keratin could not be seen if this was not done. CAM 5 2 antibody stained the bile duct epithelial cells but also stained some hepatocytes (fig 2) . There was variation in the distribution of CAM 5 2 immunoreactive hepatocytes within hepatic acini although no consistent topographical distribution could be identified. Sinusoidal cells were consistently negative with all antibodies.
The distribution of TPA, keratin, and CAM 5-2 immunoreactivity in fetal liver was similar to that seen in adult liver. In specimens taken from fetuses less than 20 weeks old, a layer one cell thick of cells positive for TPA was commonly found at the junction between parenchyma and mesoderm; in some areas this monolayer had duplicated, which corresponded to the development of primitive ductular structures ( fig 3) ; this was also seen in the livers of two fetuses 24 weeks old, but in these the monolayers were more often seen in small portal tracts.
DISTRIBUTION OF TPA AND CYTOKERATINS IN LIVER DISEASE
The profile of TPA and cytokeratin distribution in hamartomatous bile ducts in cases of congenital hepatic fibrosis was identical with that seen in normal 19) .
In this study we have shown that the distribution of TPA in the liver differs from that of low molecular weight cytokeratins and more closely resembles that Burt, Stewart, Aitchison, MacSween of higher molecular weight cytokeratins. The differences between the distribution of CAM 5-2 and keratin immunoreactivity in the liver confirm the findings of studies which have shown that normal hepatocytes contain only low molecular weight cytokeratins (52 kD "component A" and 45 kD "component D"), while bile duct epithelium also contains higher molecular weight cytokeratins. " 13 14 The pattern of staining in hepatocellular and cholangiocarcinomas resembled that of their cells of origin; staining with anti-TPA and antikeratin antibodies may help differentiate betwen these tumours and in cases of possible mixed differentiation.
In fetal liver developing bile ducts were also strongly positive for TPA. In specimens from fetuses less than 20 weeks old a layer of cells positive for TPA was often seen round portal tracts; these cells were small and cuboidal, when compared with the adjacent parenchymal cells. In some sections ductular structures had developed by a process of reduplication from these monolayers. These cells corresponded to the bile duct precursor cells previously described, and may be derived from parenchymal cells that have been transformed by the inductive effect of adjacent mesoderm.25 This process begins at seven weeks' gestation; by 16 weeks the biliary system is functionally competent. The results of our study suggest that the induction effect expression of TPA by these cells. Furthermore, although these are most abundant in fetuses of less than 20 weeks' gestation, such cells could be recognised immunohistochemically as late as 24 weeks, implying that the intrahepatic biliary system continues to develop after bile has started to flow.
Proliferating bile ducts in all cases of biliary disease showed the TPA-cytokeratin profile of normal bile duct epithelium. The so called proliferating ductules seen in biliary tract disease may result from both true proliferation of existing ducts and also from ductular metaplasia of hepatocytes.26 27 The mechanism responsible for this metaplastic change may be similar to the change that occurs in fetal liver, the induction effect in the adult being mediated by changes in the adjacent extracellular matrix and mesenchymal cells.
Abnormal hepatocytic TPA expression was found in alcoholic liver disease and primary biliary cirrhosis, both diseases associated with the presence of Mallory's bodies. The precise nature of Mallory's bodies is controversial28; ultrastructurally they show some resemblance to intermediate filaments, 29 30 although their mean diameter is greater. One and two dimensional SDS PAGE electrophoresis of solubilised Mallory's bodies has shown that they contain several polypeptides, two of which have electrophoretic features similar to those of the low molecular weight cytokeratins (components A and D) of normal hepatocytes. 16 Ray33 showed abnormal distribution of high molecular weight cytokeratins in hepatocytes in alcoholic liver disease, with a similar distribution and incidence to that which we describe for TPA, using a combination of two monoclonal antibodies, AEI and AE3. In the present study high molecular weight cytokeratin (keratin) positivity was also seen in some cases, although the intensity of staining was less than that seen with anti-TPA. This may in part reflect differences in affinity of these different antibodies on fixed tissue. Interestingly Ray35 found abnormal distribution of cytokeratin in cases of uncomplicated fatty liver similar to that of TPA in the two cases in our study. The clinical importance of this is uncertain, but it may represent an early phenotypic manifestation of chronic liver injury that will lead to the formation of Mallory's bodies.
